TrialInternational journal of hematology2019

Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemia.

Nana Arai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.